AAAAAA

   
Results: 1-25 | 26-50 | 51-63
Results: 1-25/63
REGIOSPECIFIC ELIMINATION OF A MODEL LEAVING GROUP FROM INDOLEQUINONEBIOREDUCTIVE PRODRUGS
Authors: JAFFAR M EVERETT SA NAYLOR MA MOORE SG PATEL KB STRAFFORD MRL NOLAN J STRATFORD IJ
Citation: M. Jaffar et al., REGIOSPECIFIC ELIMINATION OF A MODEL LEAVING GROUP FROM INDOLEQUINONEBIOREDUCTIVE PRODRUGS, Annals of oncology, 9, 1998, pp. 112-112
THE INFLUENCE OF ELEVATED LEVELS OF PLATELET-DERIVED ENDOTHELIAL-CELLGROWTH-FACTOR THYMIDINE PHOSPHORYLASE ON TUMORIGENICITY, TUMOR-GROWTH, AND OXYGENATION
Authors: GRIFFITHS L STRATFORD IJ
Citation: L. Griffiths et Ij. Stratford, THE INFLUENCE OF ELEVATED LEVELS OF PLATELET-DERIVED ENDOTHELIAL-CELLGROWTH-FACTOR THYMIDINE PHOSPHORYLASE ON TUMORIGENICITY, TUMOR-GROWTH, AND OXYGENATION, International journal of radiation oncology, biology, physics, 42(4), 1998, pp. 877-883
5-SUBSTITUTED ANALOGS OF NYL-1-METHYL-2-[1H-INDOLE-4,7-DIONE]PROP-2-EN-1-OL (E09, NSC-382459) AND THEIR REGIOISOMERS AS HYPOXIA-SELECTIVE AGENTS - STRUCTURE-CYTOTOXICITY IN-VITRO
Authors: JAFFAR M NAYLOR MA ROBERTSON N LOCKYER SD PHILLIPS RM EVERETT SA ADAMS GE STRATFORD IJ
Citation: M. Jaffar et al., 5-SUBSTITUTED ANALOGS OF NYL-1-METHYL-2-[1H-INDOLE-4,7-DIONE]PROP-2-EN-1-OL (E09, NSC-382459) AND THEIR REGIOISOMERS AS HYPOXIA-SELECTIVE AGENTS - STRUCTURE-CYTOTOXICITY IN-VITRO, Anti-cancer drug design, 13(2), 1998, pp. 105-123
INDOLEQUINONE ANTITUMOR AGENTS - REDUCTIVE ACTIVATION AND ELIMINATIONFROM (5-METHOXY-1-METHYL-4,7-DIOXOINDOL-3-YL)METHYL DERIVATIVES AND HYPOXIA-SELECTIVE CYTOTOXICITY IN-VITRO
Authors: NAYLOR MA SWANN E EVERETT SA JAFFAR M NOLAN J ROBERTSON N LOCKYER SD PATEL KB DENNIS MF STRATFORD MRL WARDMAN P ADAMS GE MOODY CJ STRATFORD IJ
Citation: Ma. Naylor et al., INDOLEQUINONE ANTITUMOR AGENTS - REDUCTIVE ACTIVATION AND ELIMINATIONFROM (5-METHOXY-1-METHYL-4,7-DIOXOINDOL-3-YL)METHYL DERIVATIVES AND HYPOXIA-SELECTIVE CYTOTOXICITY IN-VITRO, Journal of medicinal chemistry, 41(15), 1998, pp. 2720-2731
THYMIDINE PHOSPHORYLASE MODERATES THYMIDINE-DEPENDENT RESCUE AFTER EXPOSURE TO THE THYMIDYLATE SYNTHASE INHIBITOR ZD1694 (TOMUDEX) IN-VITRO
Authors: PATTERSON AV TALBOT DC STRATFORD IJ HARRIS AL
Citation: Av. Patterson et al., THYMIDINE PHOSPHORYLASE MODERATES THYMIDINE-DEPENDENT RESCUE AFTER EXPOSURE TO THE THYMIDYLATE SYNTHASE INHIBITOR ZD1694 (TOMUDEX) IN-VITRO, Cancer research, 58(13), 1998, pp. 2737-2740
USING GENE-THERAPY TO DETERMINE THE MECHANISM OF HYPOXIC ACTIVATION OF TIRAPAZAMINE
Authors: CHINJE EC SAUNDERS MP FRANKLIN G ROBERTSON N PATTERSON AV STRATFORD IJ
Citation: Ec. Chinje et al., USING GENE-THERAPY TO DETERMINE THE MECHANISM OF HYPOXIC ACTIVATION OF TIRAPAZAMINE, British Journal of Cancer, 78, 1998, pp. 27-27
ANALYSIS OF CELL-CYCLE EFFECTS AND SUBSEQUENT DEATH OF NONSMALL CELL LUNG-CANCER CELL-LINES AFTER SHORT-TERM MITOMYCIN-C EXPOSURE
Authors: ROBERTSON N STRATFORD IJ
Citation: N. Robertson et Ij. Stratford, ANALYSIS OF CELL-CYCLE EFFECTS AND SUBSEQUENT DEATH OF NONSMALL CELL LUNG-CANCER CELL-LINES AFTER SHORT-TERM MITOMYCIN-C EXPOSURE, British Journal of Cancer, 78, 1998, pp. 36-36
OVERCOMING CISPLATIN RESISTANCE WITH THE BIOREDUCTIVE DRUG TIRAPAZAMINE
Authors: MONAGHAN JE STRATFORD IJ
Citation: Je. Monaghan et Ij. Stratford, OVERCOMING CISPLATIN RESISTANCE WITH THE BIOREDUCTIVE DRUG TIRAPAZAMINE, British Journal of Cancer, 78, 1998, pp. 41-41
HYPOXIA INDUCIBLE FACTOR-I - EFFECT ON TUMOR BIOLOGY
Authors: DACHS GU MARPLES B WILLIAMS KJ STRATFORD IJ CHAPLIN DJ
Citation: Gu. Dachs et al., HYPOXIA INDUCIBLE FACTOR-I - EFFECT ON TUMOR BIOLOGY, British Journal of Cancer, 78, 1998, pp. 46-46
SELECTIVELY ACTIVATING BIOREDUCTIVE DRUGS IN-VITRO USING GENE-THERAPY
Authors: SAUNDERS MP PATTERSON AV RATCLIFFE PJ HARRIS AL STRATFORD IJ
Citation: Mp. Saunders et al., SELECTIVELY ACTIVATING BIOREDUCTIVE DRUGS IN-VITRO USING GENE-THERAPY, British Journal of Cancer, 78, 1998, pp. 47-47
TARGETING GENE-EXPRESSION TO HYPOXIC TUMOR-CELLS
Authors: DACHS GU PATTERSON AV FIRTH JD RATCLIFFE PJ TOWNSEND KMS STRATFORD IJ HARRIS AL
Citation: Gu. Dachs et al., TARGETING GENE-EXPRESSION TO HYPOXIC TUMOR-CELLS, Nature medicine, 3(5), 1997, pp. 515-520
TARGETING GENE-THERAPY TO CANCER - A REVIEW
Authors: DACHS GU DOUGHERTY GJ STRATFORD IJ CHAPLIN DJ
Citation: Gu. Dachs et al., TARGETING GENE-THERAPY TO CANCER - A REVIEW, Oncology research, 9(6-7), 1997, pp. 313-325
HYPOXIA RESPONSE ELEMENTS
Authors: OROURKE JF DACHS GU GLEADLE JM MAXWELL PH PUGH CW STRATFORD IJ WOOD SM RATCLIFFE PJ
Citation: Jf. Orourke et al., HYPOXIA RESPONSE ELEMENTS, Oncology research, 9(6-7), 1997, pp. 327-332
EXPLOITING HYPOXIA - BIOREDUCTIVE DRUGS AND GENE-THERAPY APPROACHES
Authors: STRATFORD IJ
Citation: Ij. Stratford, EXPLOITING HYPOXIA - BIOREDUCTIVE DRUGS AND GENE-THERAPY APPROACHES, European journal of cancer, 33, 1997, pp. 993-993
SYNTHESIS AND CYTOTOXIC ACTIVITY OF INDOLYL THIAZOLES
Authors: MOODY CJ ROFFEY JRA STEPHENS MA STRATFORD IJ
Citation: Cj. Moody et al., SYNTHESIS AND CYTOTOXIC ACTIVITY OF INDOLYL THIAZOLES, Anti-cancer drugs, 8(5), 1997, pp. 489-499
S-2-AMINO-5-(2-NITROIMIDAZOL-1-YL)PENTANOIC ACID - A MODEL FOR POTENTIAL BIOREDUCTIVELY ACTIVATED PRODRUGS FOR INHIBITORS OF NITRIC-OXIDE SYNTHASE (NOS) ACTIVITY
Authors: ULHAQ S NAYLOR MA CHINJE EC THREADGILL MD STRATFORD IJ
Citation: S. Ulhaq et al., S-2-AMINO-5-(2-NITROIMIDAZOL-1-YL)PENTANOIC ACID - A MODEL FOR POTENTIAL BIOREDUCTIVELY ACTIVATED PRODRUGS FOR INHIBITORS OF NITRIC-OXIDE SYNTHASE (NOS) ACTIVITY, Anti-cancer drug design, 12(1), 1997, pp. 61-65
HYPOXIA-INDUCIBLE FACTOR-I MODULATES GENE-EXPRESSION IN SOLID TUMORS AND INFLUENCES BOTH ANGIOGENESIS AND TUMOR-GROWTH
Authors: MAXWELL PH DACHS GU GLEADLE JM NICHOLLS LG HARRIS AL STRATFORD IJ HANKINSON O PUGH CW RATCLIFFE PJ
Citation: Ph. Maxwell et al., HYPOXIA-INDUCIBLE FACTOR-I MODULATES GENE-EXPRESSION IN SOLID TUMORS AND INFLUENCES BOTH ANGIOGENESIS AND TUMOR-GROWTH, Proceedings of the National Academy of Sciences of the United Statesof America, 94(15), 1997, pp. 8104-8109
2-CYCLOPROPYLINDOLOQUINONES AND THEIR ANALOGS AS BIOREDUCTIVELY ACTIVATED ANTITUMOR AGENTS - STRUCTURE-ACTIVITY IN-VITRO AND EFFICACY IN-VIVO
Authors: NAYLOR MA JAFFAR M NOLAN J STEPHENS MA BUTLER S PATEL KB EVERETT SA ADAMS GE STRATFORD IJ
Citation: Ma. Naylor et al., 2-CYCLOPROPYLINDOLOQUINONES AND THEIR ANALOGS AS BIOREDUCTIVELY ACTIVATED ANTITUMOR AGENTS - STRUCTURE-ACTIVITY IN-VITRO AND EFFICACY IN-VIVO, Journal of medicinal chemistry, 40(15), 1997, pp. 2335-2346
THE INFLUENCE OF OXYGEN-TENSION AND PH ON THE EXPRESSION OF PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE IN HUMAN BREAST-TUMOR CELLS GROWN IN-VITRO AND IN-VIVO
Authors: GRIFFITHS L DACHS GU BICKNELL R HARRIS AL STRATFORD IJ
Citation: L. Griffiths et al., THE INFLUENCE OF OXYGEN-TENSION AND PH ON THE EXPRESSION OF PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE IN HUMAN BREAST-TUMOR CELLS GROWN IN-VITRO AND IN-VIVO, Cancer research, 57(4), 1997, pp. 570-572
PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE IN TUMOR-GROWTH AND RESPONSE TO THERAPY
Authors: GRIFFITHS L STRATFORD IJ
Citation: L. Griffiths et Ij. Stratford, PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE IN TUMOR-GROWTH AND RESPONSE TO THERAPY, British Journal of Cancer, 76(6), 1997, pp. 689-693
ENHANCEMENT OF BIOREDUCTIVE DRUG TOXICITY IN MURINE TUMORS BY INHIBITION OF THE ACTIVITY OF NITRIC-OXIDE SYNTHASE
Authors: BUTLER SA WOOD PJ COLE S WILLIAMS C ADAMS GE STRATFORD IJ
Citation: Sa. Butler et al., ENHANCEMENT OF BIOREDUCTIVE DRUG TOXICITY IN MURINE TUMORS BY INHIBITION OF THE ACTIVITY OF NITRIC-OXIDE SYNTHASE, British Journal of Cancer, 76(4), 1997, pp. 438-444
OVEREXPRESSION OF HUMAN NADPH-CYTOCHROME-C (P450) REDUCTASE CONFERS ENHANCED SENSITIVITY TO BOTH TIRAPAZAMINE (SR 4233) AND RSU 1069
Authors: PATTERSON AV SAUNDERS MP CHINJE EC TALBOT DC HARRIS AL STRATFORD IJ
Citation: Av. Patterson et al., OVEREXPRESSION OF HUMAN NADPH-CYTOCHROME-C (P450) REDUCTASE CONFERS ENHANCED SENSITIVITY TO BOTH TIRAPAZAMINE (SR 4233) AND RSU 1069, British Journal of Cancer, 76(10), 1997, pp. 1338-1347
A COMPARISON OF THE PHYSIOLOGICAL-EFFECTS OF RSU1069 AND RB6145 IN THE SCCVII MURINE TUMOR
Authors: WOOD PJ HORSMAN MR KHALIL AA STEINBERG F STREFFER C OVERGAARD J STRATFORD IJ ADAMS GE
Citation: Pj. Wood et al., A COMPARISON OF THE PHYSIOLOGICAL-EFFECTS OF RSU1069 AND RB6145 IN THE SCCVII MURINE TUMOR, Acta oncologica, 35(8), 1996, pp. 989-994
CHIRALITY OF A 1,10-BISACETOXYMITOSENE COMPOUND - IMPACT ON REDUCTIVEACTIVATION, DNA INTERSTRAND CROSS-LINKING AND ANTITUMOR-ACTIVITY
Authors: MALIEPAARD M GROOT SE DEMOL NJ JANSSEN LHM FRERIKS M VERBOOM W REINHOUDT DN STEPHENS M STRATFORD IJ
Citation: M. Maliepaard et al., CHIRALITY OF A 1,10-BISACETOXYMITOSENE COMPOUND - IMPACT ON REDUCTIVEACTIVATION, DNA INTERSTRAND CROSS-LINKING AND ANTITUMOR-ACTIVITY, Anti-cancer drug design, 11(5), 1996, pp. 403-413
RELATIONSHIP BETWEEN TOPOISOMERASE-II LEVELS AND RESISTANCE TO TOPOISOMERASE-II INHIBITORS IN LUNG-CANCER CELL-LINES
Authors: HOULBROOK S HARRIS AL CARMICHAEL J STRATFORD IJ
Citation: S. Houlbrook et al., RELATIONSHIP BETWEEN TOPOISOMERASE-II LEVELS AND RESISTANCE TO TOPOISOMERASE-II INHIBITORS IN LUNG-CANCER CELL-LINES, Anticancer research, 16(4A), 1996, pp. 1603-1610
Risultati: 1-25 | 26-50 | 51-63